Testing effectiveness (Phase 2)Study completedNCT01477333
What this trial is testing
Addition of UT-15C SR to Pulmonary Arterial Hypertension Patients Currently Receiving Tyvaso®
Who this might be right for
Pulmonary Arterial Hypertension
United Therapeutics 18